Do you want to read an article? Please log in or register.
Chemoimmunotherapy Versus Chemotherapy for Extensive-Stage Small Cell Lung Cancer in the Real-World Setting: Retrospective Study of 904 Patients
Lung Cancer
RECOMMENDED
Related content
Lung Cancer
Real-World Treatment Patterns and Clinical Outcomes in Patients With Extensive-Stage Small Cell Lung Cancer Treated With First-Line Platinum-Based Chemotherapy and ≥ 2 Subsequent Lines of Therapy in the United States
Adv Ther
Sankar K, Unni S, Eberl M, Le H, Herrmann T, Gorsh B, Tang M, Coerts F, Ahmed S
doi: 10.1007/s12325-025-03408-z
RECOMMENDED
Lung Cancer
Real-world outcomes versus clinical trial results of first-line immunotherapy with or without chemotherapy in patients with metastatic non-small-cell lung cancer: the CORRELATE study
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
ESMO Open
Peters S, Salomonsen RJ, Diaz Perez I, Shcherbakova T, Wang A, Cai L, Sadow S, Liu SV
doi: 10.1016/j.esmoop.2025.106031
RECOMMENDED
Lung Cancer
Real-world comparative effectiveness of atezolizumab versus durvalumab for extensive-stage small-cell lung cancer
★ 1
Recommended by
Dr. med. Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Lung Cancer
Aiba T, Hara S, Tominaga S, Yamamoto R, Sakashita H, Sakaguchi T, Ando Y, Koshio J, Takigami A, Maemondo M, Sugawara S
doi: 10.1016/j.lungcan.2026.109355
Further Publications
Neoadjuvant chemoimmunotherapy in non-small-cell lung cancer patients: Effects on pulmonary function and incidence of postoperative pulmonary complications-a multicenter real-world study
Eur J Cardiothorac Surg
Zhang J, Feng Y, Dai S, Xu G, Cheng B, Jiang L, Xue LP, Liang W, Tang J
doi: 10.1093/ejcts/ezaf351
Lung Cancer
A Multi-Institutional Randomized Phase III Trial of Neoadjuvant Chemoimmunotherapy Followed By Surgery Versus Upfront Surgery in Patients With Resectable Clinical Stage II-III Non-Small Cell Lung Cancer: JCOG2317 (NATCH-ICI)
Clin Lung Cancer
Mitome N, Hamada A, Wakabayashi M, Uozumi T, Horinouchi H, Isaka M, Yotsukura M, Aokage K, Fukuda H, Watanabe SI, Tsutani Y, Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group (JCOG)
doi: 10.1016/j.cllc.2026.04.006
RECOMMENDED
Lung Cancer
Chemoimmunotherapy Combinations in Elderly Patients with Metastatic Non-Small Cell Lung Cancer and PD-L1 Expression < 50%: Results from an Italian Real-World Study
★ 1
Recommended by
Dr. med. Martin Frey, Faculty Member
J Clin Med
Veccia A, D'Argento E, Morgillo F, Pizzutilo EG, Vitiello F, Pavan A, Lombardo F, Russano M, Morabito A, Gariazzo E, Genova C, Chiari R, Cristofano A, Delconte A, Vattemi E, Dessi A, Galanti D, Busato S, Palazzolo G, Savastano C, Azzarello G, Verderame F, Mazzi C, Bencardino D, Dipasquale M, Scala A, Della Corte CM, Piscazzi D, Gilli M, Bria E, Caffo O, Gori S, Inno A
doi: 10.3390/jcm15031165
Lung Cancer
Aumolertinib Versus Osimertinib as First-Line Treatment for EGFR-Mutant Non-Small Cell Lung Cancer: A Retrospective Real-World Multicenter Study
Int J Cancer
Wang J, Qi P, Li J, Wang N, Fu C, Liu L, Li S, Li X, Hou X, Qiao H
doi: 10.1002/ijc.70617
Lung Cancer
Multicenter Real-World Data on First-Line Chemoimmunotherapy in Patients With Advanced Non-Small Cell Lung Cancer and Performance Status 2: WJOG18424L
Clin Lung Cancer
Kataoka S, Shukuya T, Ohtsu H, Miyawaki T, Fujimoto D, Hayashi H, Toi Y, Yokoyama T, Kato T, Yamaguchi T, Tanaka K, Miura S, Tamiya M, Tachihara M, Otsubo K, Sato Y, Ikeda S, Sakata S, Masuda T, Takemoto S, Yamamoto N, Okamoto I, Takahashi K
doi: 10.1016/j.cllc.2025.12.002
Lung Cancer
Real-World Clinical Outcomes of Concurrent Chemotherapy and Dose-Escalated Twice-Daily Radiotherapy With Simultaneous Integrated Boost (SIB) for Limited-Stage Small Cell Lung Cancer
Clin Lung Cancer
Celikarslan S, Sezen D, Duman M, Durankus NK, Oymak SE, Esen CSB, Rustamov A, Nasir A, Guclu SB, Kanıtez M, Kaban K, Yumuk F, Selcukbiricik F, Mandel NM, Cesur E, Erus S, Tanju S, Dilege S, Gumus T, Atasoy C, Demirkurek C, Falay O, Demirkol O, Bulutay P, Firat P, Atagun Y, Selek U
doi: 10.1016/j.cllc.2026.03.010